Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
de Mello, Camilly P. Pires
17  Ergebnisse:
Personensuche X
?
1

A human-on-a-chip approach to tackling rare diseases:

de Mello, Camilly P. Pires ; Rumsey, John ; Slaughter, Victoria.
Drug Discovery Today.  24 (2019)  11 - p. 2139-2151 , 2019
Link: https://doi.org/10.1016/..
 
?
2

Antiviral Evaluation of UV-4B and Interferon-Alpha Combinat..:

Franco, Evelyn J. ; Pires de Mello, Camilly P. ; Brown, Ashley N.
Viruses.  13 (2021)  5 - p. 771 , 2021
Link: https://doi.org/10.3390/..
 
?
3

Microphysiological heart–liver body-on-a-chip system with a..:

Pires de Mello, Camilly P. ; Carmona-Moran, Carlos ; McAleer, Christopher W....
Lab on a Chip.  20 (2020)  4 - p. 749-759 , 2020
Link: https://doi.org/10.1039/..
 
?
4

Antiviral Effects of Clinically-Relevant Interferon-α and R..:

Pires de Mello, Camilly P. ; Drusano, George L. ; Rodriquez, Jaime L...
Viruses.  10 (2018)  6 - p. 317 , 2018
Link: https://doi.org/10.3390/..
 
?
5

Oseltamivir-zanamivir combination therapy suppresses drug-r..:

Pires de Mello, Camilly P. ; Drusano, George L. ; Adams, Jonathan R....
European Journal of Pharmaceutical Sciences.  111 (2018)  - p. 443-449 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Microphysiological heart-liver body-on-a-chip system with s..:

de Mello, Camilly P. Pires ; Carmona-Moran, Carlos ; McAleer, Christopher W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123528/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
7

A human-on-a-chip approach to tackling rare diseases:

de Mello, Camilly P. Pires ; Rumsey, John ; Slaughter, Victoria.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856435/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
8

Antiviral Evaluation of UV-4B and Interferon-Alpha Combinat..:

Franco, Evelyn J ; Pires de Mello, Camilly P ; Brown, Ashley N
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145572/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

Antiviral Effects of Clinically-Relevant Interferon-α and R..:

Pires de Mello, Camilly P ; Drusano, George L ; Rodriquez, Jaime L..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024321/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
10

Clinical Regimens of Favipiravir Inhibit Zika Virus Replica..:

Pires de Mello, Camilly P ; Tao, Xun ; Kim, Tae Hwan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125552/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
11

Oseltamivir-Zanamivir Combination Therapy Suppresses Drug-R..:

Pires de Mello, Camilly P ; Drusano, George L ; Adams, Jonathan R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694373/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
12

Oseltamivir-zanamivir combination therapy suppresses drug-r..:

Institute for Therapeutic Innovation, Department of Medicine, College of Medicine, University of Florida Sanger Road, Orlando, FL 32827, United States ( host institution ) ; Pires de Mello, Camilly P. ( UF author ) ; Drusano, George L. ( UF author )...
European Journal of Pharmaceutical Sciences.  , 2018
Link: https://doi.org/10.1016/..
 
?
13

Antiviral Evaluation of UV-4B and Interferon-Alpha Combinat..:

Evelyn J. Franco ; Camilly P. Pires de Mello ; Ashley N. Brown
https://www.mdpi.com/1999-4915/13/5/771.  , 2021
Link: https://doi.org/10.3390/..
 
?
14

Antiviral Evaluation of UV-4B and Interferon-Alpha Combinat..:

Evelyn J. Franco ; Camilly P. Pires de Mello ; Ashley N. Brown
Viral Immunology, Vaccines, and Antivirals.  , 2021
Link: https://doi.org/10.3390/..
 
?
15

Antiviral Effects of Clinically-Relevant Interferon-α and R..:

Camilly P. Pires de Mello ; George L. Drusano ; Jaime L. Rodriquez..
Viral Immunology, Vaccines, and Antivirals.  , 2018
Link: https://doi.org/10.3390/..
 
1-15